Evidence map›Paper›PMID 21392483›Full record

ArticleJournal of psychiatry & neuroscience : JPN2011

Topiramate diminishes fear memory consolidation and extinguishes conditioned fear in rats.

Pedro Antônio Schmidt do Prado-Lima, Myriam Fortes Perrenoud, Christian Haag Kristensen, Martin Cammarota, Ivan Izquierdo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of psychiatry & neuroscience : JPN, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Pedro Antônio Schmidt do Prado-LimaCentro de Memória, Instituto do Cérebro, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Laboratório de Neurociências, Instituto de Pesquisas Biomédicas, PUCRS, Porto Alegre, Brazil. paspl@uol.com.br
Myriam Fortes Perrenoud
Christian Haag Kristensen
Martin Cammarota
Ivan Izquierdo
Pontifícia Universidade Católica do Rio Grande do Sul · BRBrazilian Agricultural Research Corporation · BRInstituto de Neurociencias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTopiramate has been recognized as a drug that can induce memory and cognitive impairment. Using the one-trial inhibitory avoidance task, we sought to verify the effect of topiramate on consolidation and extinction of aversive memory. Our hypothesis was that topiramate inhibits the consolidation and enhances the extinction of this fear memory.

methodsIn experiment 1, which occured immediately or 3 hours after training, topiramate was administered to rats, and consolidation of memory was verified 18 days after the conditioning session. In experiment 2, which occured 18-22 days after the training session, rats were submitted to the extinction protocol. Rats received topiramate 14 days before or during the extinction protocol.

resultsTopiramate blocked fear memory retention (p < 0.01) and enhanced fear memory extinction (p < 0.001) only when administered during the extinction protocol. LIMITATIONS: This experimental design did not allow us to determine whether topiramate also blocked the reconsolidation of fear memory.

conclusionTopira mate diminishes fear memory consolidation and promotes extinction of inhibitory avoidance memory.

Indexed as

AnimalsAvoidance LearningConditioning, PsychologicalExtinction, PsychologicalFearFructoseMaleMemoryRatsRats, WistarTopiramateFructoseTopiramate

Identifiers

PMID21392483
PMCPMC3120893
OpenAlexW102782035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.